img

Global Newborn Screening for SMA and SCID Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Newborn Screening for SMA and SCID Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

Newborn screening is the practice of testing every newborn for certain harmful or potentially fatal disorder that isn’t otherwise apparent at birth.Newborn screening is the practice of testing every newborn for certain harmful or potentially fatal disorder that isn’t otherwise apparent at birth.
Severe combined immunodeficiency (SCID) is a group of rare disorders caused by mutations in different genes involved in the development and function of infection-fighting immune cells. Infants with SCID appear healthy at birth but are highly susceptible to severe infections.
Spinal muscular atrophy (SMA) is a group of hereditary diseases that progressively destroys motor neurons—nerve cells in the brain stem and spinal cord that control essential skeletal muscle activity such as speaking, walking, breathing, and swallowing, leading to muscle weakness and atrophy.
Newborn Screening for SMA and SCID report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Newborn Screening for SMA and SCID market is projected to reach US$ 288 million in 2034, increasing from US$ 129.2 million in 2022, with the CAGR of 11.5% during the period of 2024 to 2034. Demand from SCID Screening and SMA Screening are the major drivers for the industry.
Global key players providing newborn screening for SMA and SCID are Perkinelmer, Thermo Fisher, ImmunoIVD, and Labsystems Diagnostics. The top four companies together hold 90% of the market share, with the largest vendor being Perkinelmer with 60% of the market share. The global companies providing newborn SMA and SCID screening are mainly located in North America and Europe, with North America holding the largest market share with 60%. In terms of product categories, kits dominate the market with 60% market share, followed by instruments and software with 35% and 5% market share, respectively. In terms of applications, SCID screening holds a 65% market share, while SMA screening is 35%.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Newborn Screening for SMA and SCID market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


Perkinelmer
Thermo Fisher
ImmunoIVD
Labsystems Diagnostics
Segment by Type
Instruments
Kits
Software

Segment by Application


SCID Screening
SMA Screening
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Newborn Screening for SMA and SCID market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Newborn Screening for SMA and SCID introduction, etc. Newborn Screening for SMA and SCID Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12QYResearch’s Conclusions of Newborn Screening for SMA and SCID market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Market Overview of Newborn Screening for SMA and SCID
1.1 Newborn Screening for SMA and SCID Market Overview
1.1.1 Newborn Screening for SMA and SCID Product Scope
1.1.2 Newborn Screening for SMA and SCID Market Status and Outlook
1.2 Global Newborn Screening for SMA and SCID Market Size Overview by Region 2018 VS 2022 VS 2034
1.3 Global Newborn Screening for SMA and SCID Market Size by Region (2018-2034)
1.4 Global Newborn Screening for SMA and SCID Historic Market Size by Region (2018-2024)
1.5 Global Newborn Screening for SMA and SCID Market Size Forecast by Region (2024-2034)
1.6 Key Regions, Newborn Screening for SMA and SCID Market Size (2018-2034)
1.6.1 North America Newborn Screening for SMA and SCID Market Size (2018-2034)
1.6.2 Europe Newborn Screening for SMA and SCID Market Size (2018-2034)
1.6.3 Asia-Pacific Newborn Screening for SMA and SCID Market Size (2018-2034)
1.6.4 Latin America Newborn Screening for SMA and SCID Market Size (2018-2034)
1.6.5 Middle East & Africa Newborn Screening for SMA and SCID Market Size (2018-2034)
2 Newborn Screening for SMA and SCID Market by Type
2.1 Introduction
2.1.1 Instruments
2.1.2 Kits
2.1.3 Software
2.2 Global Newborn Screening for SMA and SCID Market Size by Type: 2018 VS 2022 VS 2034
2.2.1 Global Newborn Screening for SMA and SCID Historic Market Size by Type (2018-2024)
2.2.2 Global Newborn Screening for SMA and SCID Forecasted Market Size by Type (2024-2034)
2.3 Key Regions Market Size by Type
2.3.1 North America Newborn Screening for SMA and SCID Revenue Breakdown by Type (2018-2034)
2.3.2 Europe Newborn Screening for SMA and SCID Revenue Breakdown by Type (2018-2034)
2.3.3 Asia-Pacific Newborn Screening for SMA and SCID Revenue Breakdown by Type (2018-2034)
2.3.4 Latin America Newborn Screening for SMA and SCID Revenue Breakdown by Type (2018-2034)
2.3.5 Middle East and Africa Newborn Screening for SMA and SCID Revenue Breakdown by Type (2018-2034)
3 Newborn Screening for SMA and SCID Market Overview by Application
3.1 Introduction
3.1.1 SCID Screening
3.1.2 SMA Screening
3.2 Global Newborn Screening for SMA and SCID Market Size by Application: 2018 VS 2022 VS 2034
3.2.1 Global Newborn Screening for SMA and SCID Historic Market Size by Application (2018-2024)
3.2.2 Global Newborn Screening for SMA and SCID Forecasted Market Size by Application (2024-2034)
3.3 Key Regions Market Size by Application
3.3.1 North America Newborn Screening for SMA and SCID Revenue Breakdown by Application (2018-2034)
3.3.2 Europe Newborn Screening for SMA and SCID Revenue Breakdown by Application (2018-2034)
3.3.3 Asia-Pacific Newborn Screening for SMA and SCID Revenue Breakdown by Application (2018-2034)
3.3.4 Latin America Newborn Screening for SMA and SCID Revenue Breakdown by Application (2018-2034)
3.3.5 Middle East and Africa Newborn Screening for SMA and SCID Revenue Breakdown by Application (2018-2034)
4 Newborn Screening for SMA and SCID Competition Analysis by Players
4.1 Global Newborn Screening for SMA and SCID Market Size by Players (2018-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Newborn Screening for SMA and SCID as of 2022)
4.3 Date of Key Players Enter into Newborn Screening for SMA and SCID Market
4.4 Global Top Players Newborn Screening for SMA and SCID Headquarters and Area Served
4.5 Key Players Newborn Screening for SMA and SCID Product Solution and Service
4.6 Competitive Status
4.6.1 Newborn Screening for SMA and SCID Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Perkinelmer
5.1.1 Perkinelmer Profile
5.1.2 Perkinelmer Main Business
5.1.3 Perkinelmer Newborn Screening for SMA and SCID Products, Services and Solutions
5.1.4 Perkinelmer Newborn Screening for SMA and SCID Revenue (US$ Million) & (2018-2024)
5.1.5 Perkinelmer Recent Developments
5.2 Thermo Fisher
5.2.1 Thermo Fisher Profile
5.2.2 Thermo Fisher Main Business
5.2.3 Thermo Fisher Newborn Screening for SMA and SCID Products, Services and Solutions
5.2.4 Thermo Fisher Newborn Screening for SMA and SCID Revenue (US$ Million) & (2018-2024)
5.2.5 Thermo Fisher Recent Developments
5.3 ImmunoIVD
5.3.1 ImmunoIVD Profile
5.3.2 ImmunoIVD Main Business
5.3.3 ImmunoIVD Newborn Screening for SMA and SCID Products, Services and Solutions
5.3.4 ImmunoIVD Newborn Screening for SMA and SCID Revenue (US$ Million) & (2018-2024)
5.3.5 Labsystems Diagnostics Recent Developments
5.4 Labsystems Diagnostics
5.4.1 Labsystems Diagnostics Profile
5.4.2 Labsystems Diagnostics Main Business
5.4.3 Labsystems Diagnostics Newborn Screening for SMA and SCID Products, Services and Solutions
5.4.4 Labsystems Diagnostics Newborn Screening for SMA and SCID Revenue (US$ Million) & (2018-2024)
5.4.5 Labsystems Diagnostics Recent Developments
6 North America
6.1 North America Newborn Screening for SMA and SCID Market Size by Country (2018-2034)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Newborn Screening for SMA and SCID Market Size by Country (2018-2034)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Newborn Screening for SMA and SCID Market Size by Region (2018-2034)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Newborn Screening for SMA and SCID Market Size by Country (2018-2034)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Newborn Screening for SMA and SCID Market Size by Country (2018-2034)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Newborn Screening for SMA and SCID Market Dynamics
11.1 Newborn Screening for SMA and SCID Industry Trends
11.2 Newborn Screening for SMA and SCID Market Drivers
11.3 Newborn Screening for SMA and SCID Market Challenges
11.4 Newborn Screening for SMA and SCID Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Newborn Screening for SMA and SCID Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2034
Table 2. Global Newborn Screening for SMA and SCID Market Size by Region (2018-2024) & (US$ Million)
Table 3. Global Newborn Screening for SMA and SCID Market Size Share by Region (2018-2024)
Table 4. Global Newborn Screening for SMA and SCID Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 5. Global Newborn Screening for SMA and SCID Forecasted Market Size Share by Region (2024-2034)
Table 6. Global Newborn Screening for SMA and SCID Market Size (US$ Million) by Type: 2018 VS 2022 VS 2034
Table 7. Global Newborn Screening for SMA and SCID Market Size by Type (2018-2024) & (US$ Million)
Table 8. Global Newborn Screening for SMA and SCID Revenue Market Share by Type (2018-2024)
Table 9. Global Newborn Screening for SMA and SCID Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 10. Global Newborn Screening for SMA and SCID Revenue Market Share by Type (2024-2034)
Table 11. North America Newborn Screening for SMA and SCID Revenue by Type (2018-2024) & (US$ Million)
Table 12. North America Newborn Screening for SMA and SCID Revenue by Type (2024-2034) & (US$ Million)
Table 13. Europe Newborn Screening for SMA and SCID Revenue by Type (2018-2024) & (US$ Million)
Table 14. Europe Newborn Screening for SMA and SCID Revenue by Type (2024-2034) & (US$ Million)
Table 15. Asia-Pacific Newborn Screening for SMA and SCID Revenue by Type (2018-2024) & (US$ Million)
Table 16. Asia-Pacific Newborn Screening for SMA and SCID Revenue by Type (2024-2034) & (US$ Million)
Table 17. Latin America Newborn Screening for SMA and SCID Revenue by Type (2018-2024) & (US$ Million)
Table 18. Latin America Newborn Screening for SMA and SCID Revenue by Type (2024-2034) & (US$ Million)
Table 19. Middle East and Africa Newborn Screening for SMA and SCID Revenue by Type (2018-2024) & (US$ Million)
Table 20. Middle East and Africa Newborn Screening for SMA and SCID Revenue by Type (2024-2034) & (US$ Million)
Table 21. Global Newborn Screening for SMA and SCID Market Size (US$ Million) by Application: 2018 VS 2022 VS 2034
Table 22. Global Newborn Screening for SMA and SCID Market Size by Application (2018-2024) & (US$ Million)
Table 23. Global Newborn Screening for SMA and SCID Revenue Market Share by Application (2018-2024)
Table 24. Global Newborn Screening for SMA and SCID Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 25. Global Newborn Screening for SMA and SCID Revenue Market Share by Application (2024-2034)
Table 26. North America Newborn Screening for SMA and SCID Revenue by Application (2018-2024) & (US$ Million)
Table 27. North America Newborn Screening for SMA and SCID Revenue by Application (2024-2034) & (US$ Million)
Table 28. Europe Newborn Screening for SMA and SCID Revenue by Application (2018-2024) & (US$ Million)
Table 29. Europe Newborn Screening for SMA and SCID Revenue by Application (2024-2034) & (US$ Million)
Table 30. Asia-Pacific Newborn Screening for SMA and SCID Revenue by Application (2018-2024) & (US$ Million)
Table 31. Asia-Pacific Newborn Screening for SMA and SCID Revenue by Application (2024-2034) & (US$ Million)
Table 32. Latin America Newborn Screening for SMA and SCID Revenue by Application (2018-2024) & (US$ Million)
Table 33. Latin America Newborn Screening for SMA and SCID Revenue by Application (2024-2034) & (US$ Million)
Table 34. Middle East and Africa Newborn Screening for SMA and SCID Revenue by Application (2018-2024) & (US$ Million)
Table 35. Middle East and Africa Newborn Screening for SMA and SCID Revenue by Application (2024-2034) & (US$ Million)
Table 36. Global Newborn Screening for SMA and SCID Revenue (US$ Million) by Players (2018-2024)
Table 37. Global Newborn Screening for SMA and SCID Revenue Market Share by Players (2018-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Newborn Screening for SMA and SCID as of 2022)
Table 39. Date of Key Players Enter into Newborn Screening for SMA and SCID Market
Table 40. Global Newborn Screening for SMA and SCID Key Players Headquarters and Area Served
Table 41. Newborn Screening for SMA and SCID Product Solution and Service
Table 42. Global Newborn Screening for SMA and SCID Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Perkinelmer Basic Information List
Table 45. Perkinelmer Description and Business Overview
Table 46. Perkinelmer Newborn Screening for SMA and SCID Products, Services and Solutions
Table 47. Revenue (US$ Million) in Newborn Screening for SMA and SCID Business of Perkinelmer (2018-2024)
Table 48. Perkinelmer Recent Developments
Table 49. Thermo Fisher Basic Information List
Table 50. Thermo Fisher Description and Business Overview
Table 51. Thermo Fisher Newborn Screening for SMA and SCID Products, Services and Solutions
Table 52. Revenue (US$ Million) in Newborn Screening for SMA and SCID Business of Thermo Fisher (2018-2024)
Table 53. Thermo Fisher Recent Developments
Table 54. ImmunoIVD Basic Information List
Table 55. ImmunoIVD Description and Business Overview
Table 56. ImmunoIVD Newborn Screening for SMA and SCID Products, Services and Solutions
Table 57. Revenue (US$ Million) in Newborn Screening for SMA and SCID Business of ImmunoIVD (2018-2024)
Table 58. ImmunoIVD Recent Developments
Table 59. Labsystems Diagnostics Basic Information List
Table 60. Labsystems Diagnostics Description and Business Overview
Table 61. Labsystems Diagnostics Newborn Screening for SMA and SCID Products, Services and Solutions
Table 62. Revenue (US$ Million) in Newborn Screening for SMA and SCID Business of Labsystems Diagnostics (2018-2024)
Table 63. Labsystems Diagnostics Recent Developments
Table 64. North America Newborn Screening for SMA and SCID Market Size by Country (2018-2024) & (US$ Million)
Table 65. North America Newborn Screening for SMA and SCID Market Size by Country (2024-2034) & (US$ Million)
Table 66. Europe Newborn Screening for SMA and SCID Market Size by Country (2018-2024) & (US$ Million)
Table 67. Europe Newborn Screening for SMA and SCID Market Size by Country (2024-2034) & (US$ Million)
Table 68. Asia-Pacific Newborn Screening for SMA and SCID Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 69. Asia-Pacific Newborn Screening for SMA and SCID Market Size by Region (2018-2024) & (US$ Million)
Table 70. Asia-Pacific Newborn Screening for SMA and SCID Market Size by Region (2024-2034) & (US$ Million)
Table 71. Asia-Pacific Newborn Screening for SMA and SCID Market Share by Region (2018-2024)
Table 72. Asia-Pacific Newborn Screening for SMA and SCID Market Share by Region (2024-2034)
Table 73. Latin America Newborn Screening for SMA and SCID Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 74. Latin America Newborn Screening for SMA and SCID Market Size by Country (2018-2024) & (US$ Million)
Table 75. Latin America Newborn Screening for SMA and SCID Market Size by Country (2024-2034) & (US$ Million)
Table 76. Middle East & Africa Newborn Screening for SMA and SCID Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 77. Middle East & Africa Newborn Screening for SMA and SCID Market Size by Country (2018-2024) & (US$ Million)
Table 78. Middle East & Africa Newborn Screening for SMA and SCID Market Size by Country (2024-2034) & (US$ Million)
Table 79. Newborn Screening for SMA and SCID Market Trends
Table 80. Newborn Screening for SMA and SCID Market Drivers
Table 81. Newborn Screening for SMA and SCID Market Challenges
Table 82. Newborn Screening for SMA and SCID Market Restraints
Table 83. Research Programs/Design for This Report
Table 84. Key Data Information from Secondary Sources
Table 85. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Newborn Screening for SMA and SCID Market Size Year-over-Year 2018-2034 & (US$ Million)
Figure 2. Global Newborn Screening for SMA and SCID Market Size (US$ Million), 2018 VS 2022 VS 2034
Figure 3. Global Newborn Screening for SMA and SCID Market Share by Regions: 2022 VS 2034
Figure 4. Global Newborn Screening for SMA and SCID Forecasted Market Size Share by Region (2024-2034)
Figure 5. North America Newborn Screening for SMA and SCID Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 6. Europe Newborn Screening for SMA and SCID Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 7. Asia-Pacific Newborn Screening for SMA and SCID Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 8. Latin America Newborn Screening for SMA and SCID Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 9. Middle East & Africa Newborn Screening for SMA and SCID Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 10. Product Picture of Instruments
Figure 11. Global Instruments Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 12. Product Picture of Kits
Figure 13. Global Kits Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 14. Product Picture of Software
Figure 15. Global Software Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 16. Global Newborn Screening for SMA and SCID Market Size Share by Type: 2022 & 2034
Figure 17. North America Newborn Screening for SMA and SCID Revenue Market Share by Type (2018-2034)
Figure 18. Europe Newborn Screening for SMA and SCID Revenue Market Share by Type (2018-2034)
Figure 19. Asia-Pacific Newborn Screening for SMA and SCID Revenue Market Share by Type (2018-2034)
Figure 20. Latin America Newborn Screening for SMA and SCID Revenue Market Share by Type (2018-2034)
Figure 21. Middle East and Africa Newborn Screening for SMA and SCID Revenue Market Share by Type (2018-2034)
Figure 22. SCID Screening Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 23. SMA Screening Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 24. Global Newborn Screening for SMA and SCID Market Size Share by Application: 2022 & 2034
Figure 25. North America Newborn Screening for SMA and SCID Revenue Market Share by Application (2018-2034)
Figure 26. Europe Newborn Screening for SMA and SCID Revenue Market Share by Application (2018-2034)
Figure 27. Asia-Pacific Newborn Screening for SMA and SCID Revenue Market Share by Application (2018-2034)
Figure 28. Latin America Newborn Screening for SMA and SCID Revenue Market Share by Application (2018-2034)
Figure 29. Middle East and Africa Newborn Screening for SMA and SCID Revenue Market Share by Application (2018-2034)
Figure 30. Newborn Screening for SMA and SCID Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 31. Global Top 5 and Top 10 Players Newborn Screening for SMA and SCID Market Share in 2022
Figure 32. North America Newborn Screening for SMA and SCID Market Share by Country (2018-2034)
Figure 33. United States Newborn Screening for SMA and SCID Market Size (2018-2034) & (US$ Million)
Figure 34. Canada Newborn Screening for SMA and SCID Market Size (2018-2034) & (US$ Million)
Figure 35. Germany Newborn Screening for SMA and SCID Market Size (2018-2034) & (US$ Million)
Figure 36. France Newborn Screening for SMA and SCID Market Size (2018-2034) & (US$ Million)
Figure 37. U.K. Newborn Screening for SMA and SCID Market Size (2018-2034) & (US$ Million)
Figure 38. Italy Newborn Screening for SMA and SCID Market Size (2018-2034) & (US$ Million)
Figure 39. Russia Newborn Screening for SMA and SCID Market Size (2018-2034) & (US$ Million)
Figure 40. Nordic Countries Newborn Screening for SMA and SCID Market Size (2018-2034) & (US$ Million)
Figure 41. Asia-Pacific Newborn Screening for SMA and SCID Market Share by Region (2018-2034)
Figure 42. China Newborn Screening for SMA and SCID Market Size (2018-2034) & (US$ Million)
Figure 43. Japan Newborn Screening for SMA and SCID Market Size (2018-2034) & (US$ Million)
Figure 44. South Korea Newborn Screening for SMA and SCID Market Size (2018-2034) & (US$ Million)
Figure 45. Southeast Asia Newborn Screening for SMA and SCID Market Size (2018-2034) & (US$ Million)
Figure 46. India Newborn Screening for SMA and SCID Market Size (2018-2034) & (US$ Million)
Figure 47. Australia Newborn Screening for SMA and SCID Market Size (2018-2034) & (US$ Million)
Figure 48. Latin America Newborn Screening for SMA and SCID Market Share by Country (2018-2034)
Figure 49. Mexico Newborn Screening for SMA and SCID Market Size (2018-2034) & (US$ Million)
Figure 50. Brazil Newborn Screening for SMA and SCID Market Size (2018-2034) & (US$ Million)
Figure 51. Middle East & Africa Newborn Screening for SMA and SCID Market Share by Country (2018-2034)
Figure 52. Turkey Newborn Screening for SMA and SCID Market Size (2018-2034) & (US$ Million)
Figure 53. Saudi Arabia Newborn Screening for SMA and SCID Market Size (2018-2034) & (US$ Million)
Figure 54. UAE Newborn Screening for SMA and SCID Market Size (2018-2034) & (US$ Million)
Figure 55. Bottom-up and Top-down Approaches for This Report

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries